By: P.T., STA
Salus, the Ljubljana-based pharmaceutical wholesaler, increased sales revenue by 14% last year to EUR 458.28 million as net profit rose by 28% to EUR 13 million.
In a regulatory filing with the Ljubljana Stock Exchange, the company said operating profit rose from EUR 12.26 million in 2020 to EUR 15.28 million in 2021 and EBITDA was up from EUR 16.16 million to EUR 19.67 million.
